Antibodies
Login
Search   
LEAF™ Purified anti-human GM-CSF Antibody
LEAF™ Purified anti-human GM-CSF Antibody
502203 50 µg ¥19,000     
502204 500 µg ¥56,000     

Product Details

Clone: BVD2-23B6
Isotype: Rat IgG2a, κ
Isotype Control:LEAF™ Purified Rat IgG2a, κ Isotype Ctrl
Reactivity: Human
Immunogen: E. coli -expressed, recombinant human GM-CSF
Formulation: Phosphate-buffered solution, pH 7.2, containing no preservative. 0.2 μm filter sterilized. Endotoxin level is < 0.1 EU/μg of the protein (< 0.01 ng/μg of the protein) as determined by the LAL test.
Preparation: The LEAF™ (Low Endotoxin, Azide-Free) antibody was Purified by affinity chromatography.
Concentration: 1.0 mg/ml
Storage & Handling: The antibody solution should be stored undiluted at 4° C. This LEAF™ solution contains no preservative; handle under aseptic conditions.
Application:

ELISA Capture, ELISPOT Capture, Neut, IP, WB

Recommended Usage:

Each lot of this antibody is quality control tested by ELISA assay. For ELISA capture applications, a concentration range of 0.25-1 µg/ml is recommended. To obtain a linear standard curve, serial dilutions of GM-CSF recombinant protein ranging from 500 to 4 pg/ml are recommended for each ELISA plate. It is recommended that the reagent be titrated for optimal performance for each application.

COA:
Enter Lot#:   
Application
Notes:

ELISA or ELISPOT Capture1-6: The Purified BVD2-23B6 antibody is useful as the capture antibody in a sandwich ELISA or ELISPOT assay, when used in conjunction with the biotinylated BVD2-21C11 antibody (Cat. No. 502304) as the detecting antibody. The LEAF™ Purified antibody is suggested for ELISPOT capture.
Neutralization1-4: The LEAF™ Purified antibody (Endotoxin <0.1 EU/μg, Azide-Free, 0.2 μm sterile-filtered) is recommended for neutralization of human GM-CSF bioactivity (Cat. No. 502204).
Additional reported applications (for the relevant formats) include: immunoprecipitation3 and Western blotting.
Note: For testing human GM-CSF in serum or plasma, BioLegend's ELISA Max™ Sets (Cat. No. 432001 to 432006) are specially developed and recommended.

Application
References:

1. Bacchetta R, et al. 1990. J. Immunol. 144:902.
2. Kita H, et al. 1991. J. Exp. Med. 174:745.
3. Abrams J, et al. 1992. Immunol. Rev. 127:5.
4. Abrams J, et al. 1994. Eosinophils in Allergy and Inflammation. Marcel Dekker New York. p.133.
5. Mahanty S, et al. 1992. J. Immunol. 148:3567.
6. Klinman D, et al. 1994. Curr. Prot. Immunol.. John Wiley and Sons New York. Unit 6.19.




Compare all formats



Description:

Granulocyte/macrophage - colony stimulating factor (GM-CSF) is a hematopoietic factor that is produced by activated T cells, B cells, mast cells, macrophages, fibroblasts and endothelial cells. In addition to supporting colony formation of granulocyte/macrophage progenitors, GM-CSF is a growth factor for erythroid, megakaryocyte and eosinophil progenitors. The BVD2-23B6 antibody reacts with human granulocyte/macrophage - colony stimulating factor (GM-CSF). The BVD2-23B6 antibody can neutralize the bioactivity of natural or recombinant GM-CSF.

Other Names: Granulocyte/macrophage colony-stimulating factor, CSF-α, Pluripoietin-α, Eosinophil colony stimulating factor (Eo-CSF), Burst promoting activity (BPA)
Structure: Cytokine; 22 kD (Mammalian)
Regulation: Synergistic with IL-1, IL-3, G-CSF; E21R competitive antagonist for receptor binding; stored in ECM with heparan sulfate proteoglycans
Cellular Sources: T cells, macrophages, fibroblasts, endothelial cells, mast cells
Cellular Targets: Granulocyte/macrophage/erythroid/megakaryocytic progenitors, myeloblasts, monoblasts
Receptors: Heterodimer GM-CSFR α subunit (CDw116); β-subunit (CDw131) which is also shared the IL-3 and IL-5 receptor α chains
Bioactivity/Activities: Growth/development granulocyte/macrophage progenitors; differentiates myeloblasts/monoblasts; synergizes with Epo proliferation of erythroid/megakaryocytic progenitors
Antigen
References:

1. Fitzgerald K, et al. Eds. 2001. The Cytokine FactsBook. Academic Press San Diego.
2. Demetri G, et al. 1991. Blood 78:2791.
3. Fan D, et al. 1991. In vivo 5:571.
4. Negrin R, et al. 1992. Adv. Pharmacol. 23:263.

GeneID: 1439
Latest Publications: View the latest GM-CSF articles on HighwirePress.com
UniProt: View information about GM-CSF on UniProt.org
Keywords: LEAF™ Purified anti-human GM-CSF, BVD2-23B6, LEAF™, Granulocyte/macrophage colony-stimulating factor, CSF-α, Pluripoietin-α, Eosinophil colony stimulating factor (Eo-CSF), Burst promoting activity (BPA), Human, Immunology, Antibodies
Related Products

DescriptionCloneApplications
LEAF™ Purified Rat IgG2a, κ Isotype CtrlRTK2758FC, ICFC, WB, IP, ICC, IF, IHC, FA

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/terms). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.
x
Compare Data Across All Formats
This data display is provided for general comparisons between formats. Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors. If you need assistance with selecting the best format contact our expert technical support team.

  • LEAF™ Purified anti-human GM-CSF




  • Purified anti-human GM-CSF




x
Copyright © 2012 BioLegend, Inc. All rights reserved.